z-logo
open-access-imgOpen Access
Experience of use of human leukocyte interferon in remittent course of multiple sclerosis
Author(s) -
И. А. Завалишин,
В. Т. Khaidarov,
М. Н. Захарова,
Л. С. Адарчева,
А. S. Niyazbekova,
В П Кузнецов,
D. L. Belyaev,
А. А. Babayants
Publication year - 1997
Publication title -
nevrologičeskij vestnik
Language(s) - English
Resource type - Journals
eISSN - 2304-3067
pISSN - 1027-4898
DOI - 10.17816/nb79895
Subject(s) - multiple sclerosis , medicine , interferon , immunology , normalization (sociology) , anthropology , sociology
Results of follow up of 58 patients with remittent type of course of multiple sclerosis, who were treated with human leukocyte interferon for 3 years are presented. Improvement in the course of disease of incidence of aggravation and neurological deficite, normalization of cytokines allows to recommend human leucocyte interferon for treatment of multiple sclerosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here